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Abstract 
 Background: The disease in which Grahani or  the small intestine gets vitiated and there is impairment 
of agni (digestive fire) is called Grahani. Anatomically Grahani is said to be situated above the umbilicus and 
between amashaya (stomach) and pakwashaya (intestines). Physiologically it holds the ingested food for the 
duration of its digestion before the undigested food residue is propelled into the pakwashaya (intestines).  Aim of 
study: 1) To evaluate the efficacy of Mustababbula churna in the management of Grahani. 2) To evaluate 
the efficacy the Mustababbula churna and Takrarista in the management of Grahani. Methods: This is a 
prospective, randomized clinical trial. A total of 80 patients suggestive of features of Grahani roga were enrolled 
and were randomly divided into two groups- 40 patients each. Group A treated with Mustababbula churna and 
group B were given Mustababbula churna and Takrarista. The duration of study was 3 months. Results: Both the 
groups showed statistically significant results in clinical symptoms i.e. altered bowel movements, thirst, anorexia, 
nausea, blackouts, pain in bones and joints, sour eructations etc but the mean reduction in the symptoms of group B 
was more than group A. Conclusion:  Mustababbula churna is very effective in the management of Grahani but 
when used with Takrarista it was more effective and also improved the state of agni (digestive fire).  
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Introduction:  
When the digestive fire - Agni, which resides in 
the Grahani, is affected by incorrect lifestyle and 
eating habits affects the digestive process causing 
food to be either partially digested or over digested, it 
leads to the formation of Grahani roga. Ingested food 
is to be digested, absorbed and assimilated, which is 
unavoidable for the maintenance of life, and is 
performed by Agni. (1) 
Diarrheal diseases are the most common 
infectious diseases now-a-days, and are predicted to 
remain a leading health problem. With 
contraindications of antimotility agents in infectious 
diarrhea and an increasing threat of drug resistance, 
various attempts for developing vaccines against 
diarrheal pathogens have been made. However, the 
response to vaccines in developing countries has not 
been encouraging. In the recent past, attempts have 
been made to treat infectious diarrhea with supportive 
therapy such as probiotics; but these are still under 
development. Therefore, medicinal plants may 
provide a cost-effective alternative for treatment of 
such ailments. 
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The present study was conducted using the 
ancient ayurvedic literature. Mustababbula churna and 
Takrarista were used as trial drugs. The present trial 
drug Mustababbula churna is an anubhoot preparation 
taken because of its deepan, pachana and sangrahi 
properties. Takrarista is taken from the standard text 
Charaka samhita. It contains drugs like panchlavanas, 
amalaki, haritaki, maricha, yawani, which are herbo 
mineral in nature and are easily available and the 
preparation is simple as well as cost effective.(2) 
 
Materials and Methods: 
Study design: It is a prospective, randomized type of 
clinical trial. 
Inclusion criteria: 
 Patients between the ages of 16- 65 yrs were 
included.  
 Patients with sign and symptoms of Grahani as 
explained in classics & which are devoid of any 
other complications, which does not disturb in 
treatment pattern. (3) 
Exclusion criteria: 
 Patients suffering from acute diarrhoea, intestinal 
tuberculosis, ulcerative colitis, crohn’s disease, 
sprue, celiac disease, gastric and peptic ulcer, 
associated with significant complications like 
haemorrhage, perforation, strictures, colonic 
cancer, toxic mega colon etc.  
 Patients suffering from ano-rectal diseases- 
hemorrhoids, fistula and rectal prolapse.  
 Patients suffering from systemic disorders like 
diabetes mellitus, hypertension etc, 
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hyperthyroidism and hypothyroidism, pregnancy 
and lactation, and patients who have taken 
antibiotics in the last 15 days. 
 
Selection of patients 
A total of 80 patients were randomly selected 
irrespective of sex, caste, creed, religion, economic 
status, profession or marital status. The cases were 
recorded with the help of a special proforma prepared 
for this purpose. All patients had given informed 
consent for clinical examination, investigations and 
drug administration for the purpose of this study. 
 
Grouping of patients: 
Patients were randomly divided into two groups 
of 40 each. 
 Group A: The patients were treated with 
Mustababbula churna. Out of 40 patients, 35 had 
completed the course of treatment and 5 patients 
were discontinued.  
 Group B: The patients were treated with 
Mustababbula churna and Takrarista. In this 
group, all the patients had completed the course 
of treatment.  
 During the period of treatment patients were 
examined for every 15 days and changes were 
recorded. The study and observation were clinical in 
nature. During this period of treatment the patients 
were advised to follow the pathya ahara viharas (do’s 
and don’ts) as per ayurvedic classics. 
 
Criteria of assessment: 
Assessment was done based on the improvement 
in signs and symptoms and investigations. The clinical 
symptomatology was divided into four grades (0-3) and 
change in these gradations of each symptom was to 
assess the effect of treatment provided.  
 
Subjective criteria: 
 
Altered bowel movements 
Score Grade  Criteria for grading 
 0 Absent  Regular bowel 
 1 Mild  2 times a week 
 2 Moderate  3- 4 times a week 
 3 Severe  5- 6 times a week 
Increased thirst 
 0 Absent  Normal thirst 
 1 Mild  Satiated after drinking water 
 2 Moderate  Moderately satiated after 
taking water 
 3 Severe Severely altered, not satiated by 
plain water 
Anorexia 
 0 Absent  Normal appetite 
 1 Mild  Occasional 
 2 Moderate  Daily at least two times a day 
 3 Severe Daily present most of the day 
 
Bad taste in mouth 
0 Absent  No bad taste 
1 Mild  Occasional 
2 Moderate  Frequent 
3 Severe Troublesome 
Nausea 
0 Absent  No nausea 
1 Mild  Occasional 
2 Moderate  1- 2 times per day 
3 Severe More than 2 times per day 
Blackouts 
0 Absent  No blackouts 
1 Mild  Sometimes 
2 Moderate  Often 
3 Severe Always 
Swelling over extremities 
0 Absent  No swelling 
1 Mild  Noted only on keen observation 
2 Moderate  Observable 
3 Severe Notable swelling 
Pain in bones and joints 
0 Absent  No pain 
1 Mild  Occasional 
2 Moderate  For some time everyday 
3 Severe Always/ most of the day 
Vomiting 
0 Absent  No vomiting 
1 Mild  Occasional 
2 Moderate  1- 2 times per day 
3 Severe More than 2 times per day 
Fever 
0 Absent  Afebrile 
1 Mild  98°F - 99°F 
2 Moderate  100°F - 101°F 
3 Severe 102°F- 103°F 
Sour eructation 
0 Absent  No sour eructation 
1 Mild  Occasional 
2 Moderate  Frequent/ after meals 
3 Severe Very much frequent irrespective of meal 
 
Associated symptoms 
Frequency of bowel 
0 Absent  1- 2 motions per day 
1 Mild  3- 5 motions per day 
2 Moderate  5- 7 motions per day 
3 Severe > 7 motions per day 
Mucous in stool 
0 Absent  No mucous 
1 Mild  Often little amount of mucous 
2 Moderate  Every time mucous with motion 
3 Severe Large amount of mucous with every 
stool 
Tenesmus 
0 Absent  No tenesmus 
1 Mild  Occasionally mild tenesmus 
2 Moderate  Tenesmus at every defecation 
3 Severe Severe tenesmus at every defecation, 
interrupting work 
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Trial drugs: 
Ingredients of Mustababbula churna: 
 
 
Ingredients of Takrarista: 
 
 
Method of preparation of Trial drugs: 
Mustababbula churna: Both the drugs of 
pharmacopoeial quality were taken in equal amount. 
They were then washed (first with cold water and then 
with hot water respectively), dried, and then powdered 
individually and passed through sieve number 85. Both 
ingredients were then mixed together. The churna was 
then passed through sieve number 44 to obtain a 
homogenous blend and packed in an air tight container.  
(4) 
Dose: 4- 6 grams orally with luke warm water twice a 
day after meals. The dose of patients between 16- 50 
yrs was 4 grams and for those patients between 50-65 
yrs was 6 grams respectively. 
 
Objective parameters 
Abdominal Tenderness 
0 Absent  No tenderness 
1 Mild  Subjective experience of tenderness 
2 Moderate  Wincing of face on pressure 
3 Severe Resist touching 
Drug Botanical name Part 
used 
Quantity 
Mustak Cyperus 
rotundus Linn. 
Rhizome 1 part 
Babbula Acacia Arabica 
Linn. 
Bark 1 part 
Drug Botanical 
name 
Part 
used 
Quantit
y 
Yamani Tachyspermum 
ammi Sprague 
Fruit 144 g 
Amalaki Emblica 
officinalis 
Gaertn. 
Pericarp 144 g 
Pathya Terminalia 
chebula Retz. 
Pericarp 144 g 
Maricha Piper nigrum 
Linn. 
Fruit 144 g 
Saindhava 
lavana 
Rock salt   48 g 
Sauvarcala 
lavana 
Black salt   48 g 
Vida lavana Ammonium 
chloride 
  48 g 
Samudra 
lavana 
Sea salt   48 g 
Romaka 
lavana 
Sambhar salt   48 g 
Takra  
(freshly 
prepared) 
Buttermilk   3.2 lt 
Takrarista:  
 Raw materials of pharmacopoeial quality were 
taken. Ingredient numbered 1 to 4 of the formulation 
composition were washed and crushed. Ingredients 
numbered 5 (panchlavana) of the formulation 
composition were cleaned, dried and powdered 
individually and passed through the sieve number 85 to 
obtain fine powder. All the above contents were mixed 
in freshly prepared takra. This solution was then 
strained and kept in the fermentation vessel. The mouth 
of the vessel was sealed. The container was kept in 
sunlight for 3 weeks. After 3 weeks, the lid was 
removed, and the contents examined to ascertain 
whether the process of fermentation had been completed 
according to Chakrapani’s commentary that “jatamiti 
amla rasataya jatam”. The fluid was first decanted and 
then strained after two or three days. When the fine 
suspended particles settled down, it was strained again 
and bottled. (5) 
Dose: 20 ml of Takrarista with equal water orally after 
meals, two times a day.  
 
Investigations: 
Following investigations were carried out during the 
trial: 
 Complete blood count 
 Kidney function test and Liver function test 
 Blood glucose- fasting and post prandial 
 Urine- routine and microscopic 
 Stool examination for consistency, presence of 
mucous, undigested fibres, harmful bacteria, 
viruses, occult blood, ova and cysts 
 Ultrasonography if needed 
 
Statistical analysis 
The data generated in the clinical study was 
expressed in terms of mean, standard deviation. 
Appropriate “t” test was applied to test the significance 
of comparative mean values of before and after 
treatment by using statistical software – SPSS 17.0. The 
significance was assessed at 0.05, 0.01 and 0.001 levels. 
 
Interpretation of results 
 
 
Observations and Results: 
The results were analysed on the basis of 
improvement in clinical features. Improvement in 
modern parameters of investigation was considered as 
supporting criteria. The observation of demographic 
profile revealed that males predominated the study 
Result: Criteria for assessment 
Marked relief 75 to 100% relief in signs and 
symptoms of Grahani 
Moderate 
relief 
More than 50% and less than 
75% 
Mild  relief 
More than 25% and less than 
50% 
No  relief Less than 25% was taken 
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accounting for 73.75% of total number of cases. High 
incidence was noted among moderately working 
(68.75%), semi-urban (68.75%), lower middle class 
(55%), married (66.25%), illiterate (30%) and tea and 
coffee consuming group (43.75%). 
People having vata-pitta prakriti were found 
more prone (61.25%) to Grahani. The katu (43.75%) 
and amla (22.50%) rasa consuming groups were 
affected more than rest of the patients. Common 
presenting symptoms were alternate bowel movements 
(100% in both the groups), anorexia (91.42% in group 
A and 100% in group B) and pain in bones and joints 
(82.85% in group A and 82.5% in group B).  
In group A, patients have shown highly 
significant improvement in all symptoms except in 
chardi (vomiting) and shoon pada kara (swelling in 
limbs) (p>0.05). Moderately significant in vairasya (bad 
taste in mouth)(p<0.01) and mildly significant in jwara 
(fever) (p<0.05). In group B, patients have shown 
significant improvement in all symptoms except in 
shoon pada kara (swelling in limbs) and chardi 
(vomiting) (p>0.05). Moderately significant result was 
seen in jwara (fever)(p<0.01). Between group 
comparison, group B patients have shown better rate of 
improvement.  
Observations Percentage 
Age group   
16- 25 28.75 
26- 35 35 
36- 45 18.75 
46- 55 11.25 
56- 65 6.25 
Sex   
Male 73.75 
Female 26.25 
 
Habitat   
Urban 7.5 
Semi- urban 68.75 
Rural 23.75 
Addiction   
Tobacco (smoking/chewing) 30 
Alcohol 7.5 
Tea/ coffee 43.75 
Not present 18.75 
Deha prakriti   
Vata kapha 16.25 
Pitta kapha 22.5 
Vata pitta 61.25 
Dietary habits   
Vegetarians 25 
Mixed diet 75 
Agni   
Teekshnagni 0 
Vishamagni 36.25 
Mandagni 63.75 
Dominant guna in diet   
Guru 10 
Sheeta 33.75 
Ruksha 23.75 
Laghu 8.75 
Snigdha 15 
Ushna 8.75 
Dominant rasa in diet   
Madhur 10 
Amla 22.5 
Lavana 18.75 
Katu 43.75 
Tikta 5 
Kashaya 0  
Table 1: Effect of Mustababbula churna (group A) on symptoms of Grahani 
 
 It was observed that the effect of Mustababbula churna in this study showed highly significant results 
at p< 0.001 in all symptoms except in shoon pada kara and chardi where it showed insignificant result at p> 
0.005. In Vairasya it showed moderately significant i.e p<0.01 and in Jwara it showed mildly significant 
result at p<0.05.   
Sr.
No 
Parameter BT AT % S.D. S.E. t-value “p” Result 
(df-34) 
1 Vibadh va drava mala 
(alternate bowel movements) 
1.54 0.48 68.83 0.48 0.08 12.99 <0.001 HS 
2 Trishna (thirst) 0.62 0.14 77.41 0.61 0.10 4.69 <0.001 HS 
3 Arochaka (anorexia) 1.4 0.57 59.28 0.70 0.12 6.93 <0.001 HS 
4 Vairaisya (bad taste in 
mouth) 
0.45 0.11 75.55 0.54 0.09 3.76 <0.01 Moderately 
S 
5 Prasek (nausea) 0.77 0.23 70.12 0.56 0.09 5.73 <0.001 HS 
6 Tamak (blackouts) 1.2 0.69 42.5 0.51 0.08 6.00 <0.001 HS 
7 Shoon paad kara (swelling 
in limbs) 
0.08 0.06 25 0.17 0.03 1.00 > 0.05 IS 
8 Asthi sandhi ruk (pain in 
bones and joints) 
1.23 0.60 51.21 0.59 0.10 6.21 <0.001 HS 
9 Chardi (vomitting) 0.14 0.08 42.85 0.23 0.03 1.43 > 0.05 IS 
10 Jwara (fever) 0.14 0.03 78.57 0.32 0.05 2.09 <0.05 Mildly S 
11 Tikta amla udgar (sour 
eructations) 
1.1 0.45 59.09 0.59 0.09 6.57 <0.001 HS 
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Table 2: Effect of Mustababbula churna and Takrarista (group B) on symptoms of Grahani  
 
 In this study it was observed that the effect of Mustababbula churna and Takrarista showed highly 
significant results at p< 0.001 in all symptoms except in shoon pada kara and chardi where it showed 
insignificant results at p>0.05. In Jwara it showed moderately significant result at p< 0.01. 
 
Table 3: Comparative effect of therapies on subjective parameters in Group A and Group B.  
 
 
Sr.
No 
Parameter BT AT % S.D. S.E. t-value “p” Result 
(df-39) 
1 Vibadh va drava mala 
(alternate bowel 
movements) 
1.37 0.25 81.75 0.61 0.95 11.72 <0.001 HS 
2 Trishna (thirst) 0.90 0.15 83.33 0.74 0.11 6.38 <0.001 HS 
3 Arochaka (anorexia) 0.7 0.15 78.57 0.67 0.10 5.13 <0.001 HS 
4 Vairaisya (bad taste in 
mouth) 
0.72 0.05 93.05 0.57 0.09 7.45 <0.001 HS 
5 Prasek (nausea) 0.72 0.05 93.05 0.57 0.09 7.45 <0.001 HS 
6 Tamak (blackouts) 1.02 0.45 55.88 0.63 0.10 5.71 <0.001 HS 
7 Shoon paad kara (swelling 
in limbs) 
0.12 0.07 41.66 0.22 0.03 1.43 > 0.05 IS 
8 Asthi sandhi ruk (pain in 
bones and joints) 
1.12 0.43 61.60 0.68 0.11 6.44 <0.001 HS 
9 Chardi (vomiting) 0.12 0.05 58.33 0.26 0.04 1.77 > 0.05 IS 
10 Jwara (fever) 0.2 0.05 75 0.36 0.05 2.62 <0.01 Moderately S 
11 Tikta amla udgar (sour 
eructations) 
1.07 0.35 67.28 0.64 0.10 7.16 <0.001 HS 
Sr.
No 
Chief complaints 
No. of 
patients 
Mean S.D S.E t 
valu
e 
P 
valu
e 
  
A B A B A B A B 
1 Vibadh va drava 
mala (alternate 
bowel movements) 
35 40 0.48 0.25 0.56 0.43 0.09 0.06 2.03 0.04 Mildl
y S 
2 Trishna (thirst) 18 26 0.14 0.15 0.35 0.36 0.06 0.05 -0.08 0.9 IS 
3 Arochaka 
(anorexia) 
32 40 0.57 0.50 0.65 0.59 0.11 0.09 0.49 0.62 IS 
4 Vairaisya (bad taste 
in mouth) 
14 19 0.11 0.15 0.32 0.42 0.05 0.06 -0.40 0.68 IS 
5 Prasek (nausea) 22 25 0.02 0.05 0.16 0.22 0.02 0.03 -0.47 0.64 IS 
6 Tamak (blackouts) 28 31 0.68 0.45 0.67 0.55 0.11 0.08 1.66 0.10 IS 
7 Shoon paad kara 
(swelling in limbs) 
02 04 0.05 0.07 0.23 0.26 0.03 0.04 -0.30 0.76 IS 
8 Asthi sandhi ruk 
(pain in bones and 
joints) 
29 33 0.60 0.42 0.65 0.50 0.11 0.07 1.31 0.19 IS 
9 Chardi (vomitting) 04 04 0.08 0.05 0.28 0.22 0.04 0.03 0.60 0.54 IS 
10 Jwara (fever) 05 07 0.02 0.05 0.16 0.22 0.02 0.03 -0.46 0.64 IS 
11 Tikta amla udgar 
(Sour eructations) 
27 31 0.45 0.35 0.65 0.53 0.11 0.08 0.77 0.43 IS 
12 Frequency of stool 35 38 0.31 0.22 0.47 0.47 0.07 0.07 0.81 0.42 IS 
13 Mucus in stool 09 11 0.14 0.10 0.42 0.30 0.07 0.04 0.50 0.61 IS 
14 Tenesmus 14 15 0.22 0.10 0.42 0.30 0.07 0.04 1.51 0.13 IS 
15 Abdominal 
tenderness 
15 18 0.20 0.20 0.40 0.40 0.06 0.06 0.00 1.00 IS 
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 On comparing the effect of therapies, it was observed that the difference in the results were 
insignificant at p>0.05 in all symptoms except in alternate bowel movement where it was observed to be 
mildly significant at p< 0.05. 
 
Table No 4: Comparative effect of therapies on objective parameters in Group A and Group B. 
 
On comparing the effect of therapies on objective parameters it was observed that there was insignificant 
difference between the therapies in hemoglobin and weight of the patients. 
In Group A, 8.5 % patients got mild relief, 17.14 % got moderate relief and 68.57 % patients got marked 
relief. In Group B, 7.5 % patients got mild relief, 17.5 % patients got moderate relief and 80 % patients got 
marked relief. On comparison between the groups it was observed that in all the parameters the difference 
was statistically insignificant except in altered bowel movement where the difference was statistically 
mildly significant.  
Sr.
No 
Objective 
parameter 
No. of patients Mean S.D S.E T p   
A B A B A B A B 
1 Hb % 35 40 12.0 12.0 1.40 1.40 0.24 0.22 -0.03 0.97 IS 
2 Weight 35 40 56.5 54.7 5.32 5.57 0.89 0.88 1.42 0.15 IS 
Discussion:  
In today’s era of lifestyle changes, improper 
food and dietary habits, the digestive system has 
suffered the most. Grahani roga is a disease where 
“Grahani” as a structure is unable to perform its 
normal function of holding on the uncooked food 
particles till they get digested. Grahani is a disease 
in which agni (digestive power) is at fault. So, to 
enhance the potency of agni, thereby reducing the 
formation of Ama Dosha, the trial drugs were 
selected. 
In this study, 73.75% patients were males 
attributing to their unavoidable exposure to 
external environment along with food habits and 
drinking of contaminated water. Maximum 
incidence was observed in 3rd followed by 2nd 
decade of life. Young adults of these age groups 
are more exposed to unhygienic eating habits and 
mental stress. It was also observed that tea/ coffee 
intake group was affected more because tea/ coffee 
cause irritation in the gastrointestinal tract. 
Maximum patients had vata pitta prakriti which 
signifies that if such persons get indulged in vata 
and pitta aggravating factors, it may result in agni 
dushti as well as vitiation of samana vayu (more 
than patients with other prakriti) which are the 
main causes of Grahani roga. Both the groups 
showed statistically significant results in clinical 
symptoms i.e. altered bowel movements, thirst, 
anorexia, nausea, blackouts, pain in bones and 
joints, sour eructations, but the mean reduction in 
the symptoms of group B was more than group A. 
Better effect of group B were observed which may 
be due to better absorption of Takrarista and also 
because arishta is Deepana (appetizer) by nature. 
 
Mode of action of drugs: 
Musta (Cyperus rotundus) is pungent, bitter 
and astringent in taste, pungent in the post 
digestive effect and has cold potency. Acharya 
Charaka and Vagbhata has mentioned it as 
Dipaniya (appetizer), Pachaniya (digestant) and 
Sangrahi (anti-diarrhoeal). It is also well known 
for its Amapacaka property (digests ama). (6) 
Musta has limited activity against different 
forms of infectious diarrhoea due to its selective 
activity against diarrheal pathogens, in the absence 
of a marked activity, this plant seems to have anti-
diarrheal action because of its action on some 
features like bacterial colonization, production of 
cholera toxin and action on labile toxin. (7) 
Babbula (Acacia arabica) is astringent in 
taste, pungent in post digestive effect and has cold 
potency. It possesses astringent property which 
makes it very useful in bleeding disorders like 
bloody diarrhoea. It offers marked liver protection 
and has anti- oxidant activity. Anti- bacterial 
activity has also been reported with highest activity 
against Escherichia coli, Staphylococcus aureus 
and Salmonella typhi. (8) 
Takrarista is an ayurvedic formulation and is 
indicated against haemorrhoids, worm infestation, 
loss of appetite, grahani and diarrhoea. Most of the 
drugs used in this compound are Laghu and 
Tikshna in guna and has Ushna potency and 
therefore has deepan and grahi property. Takra in 
Takrarista is a fermented product and 
refermentation of the same with some more salts 
and herbal drugs yields more stable product 
containing little amount of alcohol and dominant 
characters of acidic fermentation. (9) 
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Lactic acid bacteria present in curd are 
reported for the anti- microbial activity due to the 
production of antibiotics like substances and 
peptides. Amla, harda, ajowan and maricha which 
are used in GI disorders, have also exhibited anti 
microbial activity. Piperin obtained from maricha is 
a bio- availability enhancer. So, the anti-bacterial 
activity of Takrarista may be ascribed to the 
presence of metabolites of lactic acid bacteria, anti- 
bacterial activity of herbal constituents and 
conversion products formed by microbial activity 
during fermentation. (10) 
 
Scope of future research: 
Larger number of sample size should be 
included to confirm our results and generalize the 
results to population outside this sample 
population. 
 
Conclusion:     
This is evident from both clinical and 
statistical improvement that the drugs 
Mustababbula churna and Takrarista are effective 
in the treatment of Grahani. The drug 
Mustababbool Churna is an anubhoot preparation 
and Takrarista described by Acharya Charaka in 
the management of Grahani Dosha, which was 
selected for study is an excellent combination of 
Deepana, Pachana drugs. Mustak exhibit the anti-
diarrheal action because of its action on some 
features like bacterial virulence viz., bacterial 
colonization, production of Cholera Toxin and 
action of Labile Toxin. Acacia arabica offers 
marked liver protection, and has anti- oxidant 
activity. Takrarista has anti-diarrhoeal, anti-
haemorrhoidal, anti-bacterial and anti-helmintic 
activity owing to the presence of metabolites of 
lactic acid bacteria, anti- bacterial activity of herbal 
constituents and conversion products formed by 
microbial activity during fermentation. 
It can be concluded from the present study 
that Mustababbool churna is very effective in the 
management of Grahani but when used with 
Takrarista it was more effective and also improve 
the state of Agni.   
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